These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20537558)

  • 1. Transdermal scopolamine patch with odansetron for the control of nausea after uterine artery embolization compared with odansetron alone: results of a randomized placebo-controlled trial.
    Lee JS; Costantino M; McCullough MF; Lee JB; Jones MM; Carter EA; Spies JB
    J Vasc Interv Radiol; 2010 Jul; 21(7):1018-23. PubMed ID: 20537558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery.
    Sah N; Ramesh V; Kaul B; Dalby P; Shestak K; Vallejo MC
    J Clin Anesth; 2009 Jun; 21(4):249-52. PubMed ID: 19502023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery.
    Harnett MJ; O'Rourke N; Walsh M; Carabuena JM; Segal S
    Anesth Analg; 2007 Sep; 105(3):764-9. PubMed ID: 17717237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative transdermal scopolamine does not reduce the level of nausea and frequency of vomiting after laparoscopic cholecystectomy.
    Sohi HS; Heipel J; Inman KJ; Chinnick B; Cunningham DG; Holliday RL; Girotti MJ
    Can J Surg; 1994 Aug; 37(4):307-12. PubMed ID: 8055388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scopolamine for prevention of postoperative nausea in gynecologic laparoscopy, a randomized trial.
    Einarsson JI; Audbergsson BO; Thorsteinsson A
    J Minim Invasive Gynecol; 2008; 15(1):26-31. PubMed ID: 18262140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy.
    Arpornwirat W; Albert I; Hansen VL; Levin J; Bandekar RR; Grunberg SM
    Cancer; 2009 Dec; 115(24):5807-16. PubMed ID: 19834961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of transdermal scopolamine on the incidence and severity of postoperative nausea and vomiting in a group of high-risk patients given prophylactic intravenous ondansetron.
    Jones S; Strobl R; Crosby D; Burkard JF; Maye J; Pellegrini JE
    AANA J; 2006 Apr; 74(2):127-32. PubMed ID: 16617916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nausea prophylaxis using transdermal scopolamine in the setting of patient-controlled analgesia.
    Harris SN; Sevarino FB; Sinatra RS; Preble L; O'Connor TZ; Silverman DG
    Obstet Gynecol; 1991 Oct; 78(4):673-7. PubMed ID: 1923171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment of patients requiring oral contrast abdominal computed tomography with antiemetics: a randomized controlled trial of efficacy.
    Garra G; Singer AJ; Bamber D; Chohan J; Troxell R; Thode HC
    Ann Emerg Med; 2009 Apr; 53(4):528-33. PubMed ID: 18640743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved outcome with chronic subcutaneous infusion of odansetron for intractable nausea and vomiting.
    Macario A; Ronquillo RB; Brose WG; Gaeta RR
    Anesth Analg; 1996 Jul; 83(1):194-5. PubMed ID: 8659741
    [No Abstract]   [Full Text] [Related]  

  • 12. Transderm scopolamine for the control of perioperative nausea.
    Stromberg BV; Reines DH; Ackerly J
    Am Surg; 1991 Nov; 57(11):712-5. PubMed ID: 1746779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
    Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.
    Herrstedt J; Sigsgaard T; Boesgaard M; Jensen TP; Dombernowsky P
    N Engl J Med; 1993 Apr; 328(15):1076-80. PubMed ID: 8455664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: a double-blind, randomized study.
    Reinhart DJ; Klein KW; Schroff E
    Anesth Analg; 1994 Aug; 79(2):281-4. PubMed ID: 7639364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total control of chemotherapy induced emesis.
    Helson L
    Anticancer Res; 1992; 12(6B):2243-4. PubMed ID: 1295471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granisetron and ondansetron for chemotherapy-related nausea and vomiting.
    Zeidman A; Ben Dayan D; Ben Zion T; Kaufman O; Cohen AM; Mittelman M
    Haematologia (Budap); 1998; 29(1):25-31. PubMed ID: 9704254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiemetic-related dystonic reaction unmasked by removal of a scopolamine transdermal patch.
    Roberge RJ
    J Emerg Med; 2006 Apr; 30(3):299-302. PubMed ID: 16677982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO
    Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.